Biopharmaceutical Cell Culture Market

The biopharmaceutical cell culture market is projected to grow from USD 12.81 billion in 2025 to USD 24.47 billion by 2031, at a CAGR of 13.8% during the forecast period. The biopharmaceutical cell culture market is expanding rapidly due to increasing demand for monoclonal antibodies, growing regulatory approvals for cell culture-based vaccines, and rising incidence of infectious diseases, among other factors.

The biopharmaceutical cell culture market is dominated by major players, including Thermo Fisher Scientific (US), Danaher (US), Corning Incorporated (US), Merck KGaA (Germany), and Sartorius AG (Germany). Leading biopharmaceutical cell culture players stay competitive by expanding biomanufacturing facility capacity, adopting single-use technologies and advanced bioreactor systems, refining consumables portfolios including media and sera, forming strategic partnerships with pharmaceutical developers, and delivering faster, cost-efficient, regulatory-compliant cell culture solutions across biopharmaceutical production.

To know about the assumptions considered for the study download the pdf brochure

Thermo Fisher Scientific (US) is a leading global provider of comprehensive cell culture products for biopharmaceutical manufacturing. Its integrated portfolio combines equipment, consumables, media, sera, and reagents with biomanufacturing services, enabling simultaneous progress in process development and commercial production, substantially accelerating timelines while maintaining high quality and regulatory compliance. The company delivers a full suite of solutions, including bioreactors, cell culture media, single-use systems, process development services, and contract manufacturing for monoclonal antibody production, vaccine development, cell therapy, gene therapy, and recombinant protein manufacturing. With decades of experience and significant facility investments, Thermo Fisher has established itself as a trusted partner for small- to large-scale biopharmaceutical cell culture operations in the region.

Danaher (US) is a technology-driven life sciences and diagnostics corporation specializing in advanced cell culture systems, bioprocessing equipment, and consumables for biopharmaceutical production facilities globally. Through its Cytiva and other life sciences platforms, Danaher integrates equipment design, consumables manufacturing, and bioprocessing expertise into a single solution that significantly reduces development time, production costs, and operational complexity compared to traditional methods. Its proprietary bioreactor platforms and single-use systems enable scalable production from research through commercial manufacturing, offering substantial process certainty, reduced contamination risk, and enhanced productivity and sustainability. Danaher's comprehensive product range, including cell culture media, chromatography systems, filtration products, bioreactors, and process analytics, completed with full technical support, offers biopharmaceutical manufacturers a complete solution that speeds up product development and commercialization without compromising quality.

MARKET RANKING

Thermo Fisher Scientific (US), Danaher (US), Corning Incorporated (US), Merck KGaA (Germany), and Sartorius AG (Germany) are the leading companies in the biopharmaceutical cell culture market. Thermo Fisher Scientific is recognized for its comprehensive cell culture solutions, spanning consumables, equipment, and biomanufacturing services for monoclonal antibody and vaccine production, supported by high-capacity facilities and recent global expansions. Danaher specializes in advanced bioprocessing systems through its subsidiary, Cytiva, integrating digital process control, automated bioreactors, and single-use technologies for commercial biopharmaceutical manufacturing and cell therapy applications. Corning Incorporated leverages its proprietary surface technology, combined with a broad portfolio of cell culture consumables, to ensure reproducibility, scalability, and improved cell growth performance. Merck KGaA specializes in cell culture media, sera, reagents, and process solutions for biopharmaceutical production, utilizing extensive quality control and regulatory expertise to deliver consistent, compliant materials. Sartorius AG is known for its integrated bioprocess solutions combining bioreactors, filtration systems, and single-use technologies, emphasizing process efficiency, automation, and scalable platforms across diverse biopharmaceutical manufacturing applications.

Related Reports:

Biopharmaceutical Cell Culture Market by Product [Consumables (Media, Sera, Reagents; Accessories), Equipment (Bioreactors, Centrifuges, Filters, Incubators, Freezers)], Type (mAbs, Vaccines, Other), End User (Biopharma, CMOs) - Global Forecast to 2031

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
1615 South Congress Ave.
Suite 103, Delray Beach, FL 33445
USA : 1-888-600-6441
sales@marketsandmarkets.com